Light and Laser Modalities in the Treatment of Cutaneous Sarcoidosis: A Systematic Review

Ana Luiza Lima1, Steven Goetze, Tanja Illing

  • 1Department of Dermatology, University Hospital Jena, Erfurter Str. 35, DE-07743 Jena, Germany. ana.lima@med.uni-jena.de.

Acta Dermato-Venereologica
|December 16, 2017
PubMed

Insights

Cutaneous sarcoidosis is challenging to treat, but light and laser therapies show promise. This review summarizes available treatments like intense pulsed light, photodynamic therapy, and various lasers for skin sarcoidosis.

Area of Science:

  • Dermatology
  • Immunology
  • Medical Technology

Background:

  • Sarcoidosis is a systemic granulomatous disease with variable cutaneous involvement.
  • Cutaneous sarcoidosis affects 10-30% of patients and can be disfiguring or disabling.
  • Effective treatments for cutaneous sarcoidosis are limited, necessitating exploration of novel therapies.

Purpose of the Study:

  • To systematically review the literature on light and laser therapies for cutaneous sarcoidosis.
  • To summarize treatment modalities and outcomes reported for these advanced therapies.
  • To identify potential therapeutic alternatives for difficult-to-treat skin sarcoidosis.

Main Methods:

  • Systematic literature review of English and German publications from January 1990 to July 2016.
  • Searches conducted in PubMed, MEDLINE, Embase, and Scopus databases.
  • Analysis of case reports and case series detailing light and laser treatments.

Main Results:

  • Various light therapies including intense pulsed light, photodynamic therapy, and UVA therapy were described.
  • Laser therapies such as pulsed dye laser, YAG laser, and Q-switched ruby laser were documented.
  • Evidence is primarily based on individual case reports and small case series, lacking randomized controlled trials.

Conclusions:

  • Light and laser therapies represent a potentially promising treatment avenue for cutaneous sarcoidosis.
  • Further research, particularly randomized controlled trials, is needed to establish efficacy and safety.
  • These modalities may offer alternatives for patients with refractory or cosmetically concerning skin sarcoidosis.